These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 14635080

  • 1. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS, Arndt CA.
    Cancer; 2003 Dec 01; 98(11):2447-56. PubMed ID: 14635080
    [Abstract] [Full Text] [Related]

  • 2. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 3. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K.
    J Clin Oncol; 2005 Jan 20; 23(3):559-68. PubMed ID: 15659502
    [Abstract] [Full Text] [Related]

  • 4. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
    Chou AJ, Merola PR, Wexler LH, Gorlick RG, Vyas YM, Healey JH, LaQuaglia MP, Huvos AG, Meyers PA.
    Cancer; 2005 Nov 15; 104(10):2214-21. PubMed ID: 16206297
    [Abstract] [Full Text] [Related]

  • 5. Metastatic osteosarcoma.
    Daw NC, Billups CA, Rodriguez-Galindo C, McCarville MB, Rao BN, Cain AM, Jenkins JJ, Neel MD, Meyer WH.
    Cancer; 2006 Jan 15; 106(2):403-12. PubMed ID: 16353204
    [Abstract] [Full Text] [Related]

  • 6. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O.
    Cancer; 2005 Sep 01; 104(5):1100-9. PubMed ID: 16015627
    [Abstract] [Full Text] [Related]

  • 7. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G, Longhi A, Cesari M, Versari M, Bertoni F.
    Cancer; 2006 Jun 15; 106(12):2701-6. PubMed ID: 16691623
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P.
    Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923
    [Abstract] [Full Text] [Related]

  • 12. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group.
    J Clin Oncol; 2008 Feb 01; 26(4):633-8. PubMed ID: 18235123
    [Abstract] [Full Text] [Related]

  • 13. Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide.
    Lin F, Wang Q, Yu W, Tang L, Zheng S, Sun Y, Shen Z, Yao Y, Dong Y.
    Asia Pac J Clin Oncol; 2011 Sep 01; 7(3):270-5. PubMed ID: 21884438
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 01; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival after recurrence of Ewing's sarcoma family of tumors.
    Barker LM, Pendergrass TW, Sanders JE, Hawkins DS.
    J Clin Oncol; 2005 Jul 01; 23(19):4354-62. PubMed ID: 15781881
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Resection of recurrent pulmonary metastases in patients with osteosarcoma.
    Briccoli A, Rocca M, Salone M, Bacci G, Ferrari S, Balladelli A, Mercuri M.
    Cancer; 2005 Oct 15; 104(8):1721-5. PubMed ID: 16155943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.